| 000 | 01029 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512110346.0 | ||
| 264 | 0 | _c19750718 | |
| 008 | 197507s 0 0 eng d | ||
| 022 | _a0301-5149 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGasson, A G | |
| 245 | 0 | 0 |
_aSome problems associated with sterility testing in a commercial organization. _h[electronic resource] |
| 260 |
_bDevelopments in biological standardization _c1974 |
||
| 300 |
_a151-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBacteria _xisolation & purification |
| 650 | 0 | 4 | _aBacterial Vaccines |
| 650 | 0 | 4 | _aBiological Products |
| 650 | 0 | 4 | _aDrug Contamination |
| 650 | 0 | 4 | _aDrug Industry |
| 650 | 0 | 4 |
_aEthylmercury Compounds _xpharmacology |
| 650 | 0 | 4 | _aFiltration |
| 650 | 0 | 4 | _aImmune Sera |
| 650 | 0 | 4 |
_aPhenols _xpharmacology |
| 650 | 0 | 4 | _aPreservation, Biological |
| 650 | 0 | 4 | _aSterilization |
| 650 | 0 | 4 | _aViral Vaccines |
| 773 | 0 |
_tDevelopments in biological standardization _gvol. 23 _gp. 151-6 |
|
| 999 |
_c4463715 _d4463715 |
||